N
Nora D. Volkow
Researcher at National Institute on Drug Abuse
Publications - 1038
Citations - 121498
Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.
Papers
More filters
Journal ArticleDOI
A non-invasive method for detecting the metabolic stress response in rodents: characterization and disruption of the circadian corticosterone rhythm.
Panayotis K. Thanos,Sonia A. Cavigelli,Michael Michaelides,Michael Michaelides,Doreen M. Olvet,Doreen M. Olvet,Ujval B. Patel,Ujval B. Patel,Mai N. Diep,Nora D. Volkow +9 more
TL;DR: Results indicate fecal CORT metabolite measures can be used to assess conditions that disrupt the circadian CORT rhythm, and provide a method to measure long-term changes in CORT production.
Journal ArticleDOI
Re-energizing the Development of Pain Therapeutics in Light of the Opioid Epidemic.
Phil Skolnick,Nora D. Volkow +1 more
TL;DR: Addressing the factors contributing to a dearth of effective alternatives and re-energizing the development of pain therapeutics is necessary to quell this epidemic.
Journal ArticleDOI
The biological bases of nicotine and alcohol co-addiction.
Journal ArticleDOI
Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers
Nora D. Volkow,Gene-Jack Wang,Dardo Tomasi,Frank Telang,Joanna S. Fowler,Kith Pradhan,Millard Jayne,Jean Logan,Rita Z. Goldstein,Nelly Alia-Klein,Christopher Wong +10 more
TL;DR: Assessment of the effects of increasing tonic dopamine levels (using oral methylphenidate) on brain activation induced by cocaine-cues in cocaine abusers suggests thatethylphenidate's attenuation of brain reactivity to Cocaine-cue is distinct from that involved in craving.
Posted ContentDOI
COVID infection severity in children under 5 years old before and after Omicron emergence in the US
TL;DR: For children under age 5, first time SARS-CoV-2 infections occurring when the Omicron predominated was associated with significantly less severe outcomes than first-time infections in similar children when the Delta variant predominated.